Get email alerts and dashboard notifications when your medications are recalled by the FDA.
Or login with:
There are currently no manufacturer details available.
Lymphazurin™ 1% is to be administered subcutaneously, one-half (1/2) ml into three (3) interdigital spaces of each extremity per study. A maximum dose of 3 ml (30 mg) isosulfan blue is, therefore, injected.